- Home
- AVNW vs VNDA Comparison
AVNW vs VNDA Comparison
Compare AVNW & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVNW
- VNDA
- Stock Information
- Founded
- AVNW 2006
- VNDA 2002
- Country
- AVNW United States
- VNDA United States
- Employees
- AVNW N/A
- VNDA N/A
- Industry
- AVNW Radio And Television Broadcasting And Communications Equipment
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- AVNW Technology
- VNDA Health Care
- Exchange
- AVNW Nasdaq
- VNDA Nasdaq
- Market Cap
- AVNW 258.9M
- VNDA 237.9M
- IPO Year
- AVNW 2007
- VNDA 2006
- Fundamental
- Price
- AVNW $21.70
- VNDA $4.39
- Analyst Decision
- AVNW Strong Buy
- VNDA Strong Buy
- Analyst Count
- AVNW 5
- VNDA 3
- Target Price
- AVNW $37.60
- VNDA $15.33
- AVG Volume (30 Days)
- AVNW 90.2K
- VNDA 506.2K
- Earning Date
- AVNW 05-06-2025
- VNDA 07-30-2025
- Dividend Yield
- AVNW N/A
- VNDA N/A
- EPS Growth
- AVNW N/A
- VNDA N/A
- EPS
- AVNW N/A
- VNDA N/A
- Revenue
- AVNW $435,926,000.00
- VNDA $201,351,000.00
- Revenue This Year
- AVNW $8.46
- VNDA $16.86
- Revenue Next Year
- AVNW $5.21
- VNDA $39.78
- P/E Ratio
- AVNW N/A
- VNDA N/A
- Revenue Growth
- AVNW 14.58
- VNDA 13.37
- 52 Week Low
- AVNW $12.96
- VNDA $3.81
- 52 Week High
- AVNW $31.74
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- AVNW 61.35
- VNDA 53.38
- Support Level
- AVNW $20.03
- VNDA $4.24
- Resistance Level
- AVNW $22.81
- VNDA $4.42
- Average True Range (ATR)
- AVNW 0.83
- VNDA 0.15
- MACD
- AVNW 0.05
- VNDA 0.03
- Stochastic Oscillator
- AVNW 71.97
- VNDA 78.12
About AVNW Aviat Networks Inc.
Aviat Networks Inc is a networking solutions provider. It designs, manufactures and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.